Vivo Ventures
Vivo boosts fund for cross-border play
Healthcare-focused Vivo Capital has attracted increasing attention from LPs for its hybrid focus on the US and China. As testament to this, its latest fund - Vivo Capital Fund VIII - closed at $750 million after nine months in the market, with demand...
Vivo closes latest Sino-US healthcare fund at $750m
US-based Vivo Capital has closed its eighth fund at $750 million. It will invest in healthcare companies in the US and China.
Vivo Ventures closes seventh fund at $375m
Vivo Ventures, the US and Greater China-focused healthcare investment firm, has closed its seventh fund at $375 million. The firm now has more than $1 billion under management.